Trade
Group Sites
Premia
Business Partners
Wealth
FLAME
Property Solutions
IIFL Finance
IIFL MF
IIFL Associates
About IIFl
Contact IIFl
Investor Relations
We're HIRING
FEEDBACK
Register
Login
Sensex
19,674.33
-387.91
-1.93%
Nifty
5,967.05
-127.45
-2.09%
Commodity Ideas
Stock Ideas
IIFL Live
Customer Service
Corporate News
IIFL
Quote
News
Quotes
View all
MF
View all
Insurance
View all
Commodity
View all
No Result found
Home
Markets
Equities
Market Statistics
Charts
Market Map
Derivatives
Commodity
IPO
Companies
News
Overview
Top
Business
Corporate
Equities
Commodity
Currency
MF
Insurance
IPO
Economy
Global
M&A
Gold
PR Newswire
Dow Jones
Business Wire
Research & Ideas
Overview
Recommendations
Sectors
Market Analysis
Leader Speak
Featured Reports
Sector Indices
Articles
In Focus
Calendar
Economy
Mutual Funds
Fund Snapshot
Fund Houses
Equity Funds
Debt Funds
Balanced Funds
ETFs
NFO Updates
Dividend Tracker
Fund Manager Speak
Apply Online
Discuss
Discussions
Polls
Videos
Chat With Experts
Live TV
Personal Finance
Overview
Insurance
NRI Corner
Loans
Calculators
Articles
Union Budget
Railway Budget
Data Monitor
Blog
Portfolio
Company Snapshot
Research
India Infoline Research
MF Investments
FII Investments
Bulk Deals
Block Deals
Daily Share Prices
Monthly Share Prices
Fundamentals
Profit & Loss
Balance Sheet
Cash Flow
Key Ratios
Management
Discussions
Share Holding Pattern
Equity Capital
Structure
Director's Report
Auditor's Report
Quarterly Results
Half Yearly Results
Nine Monthly Results
Annual Results
Background
Key Executives
Board of Directors
Meeting Schedule
Stock history
Company Profile
Products & Services
Raw Materials
Finished Goods
Bankers
Auditors
Location
News
Company News
Sector News
Corporate
Announcements
IndiaInfoline
Markets
Companies
Caplin Point Laboratories Ltd
BSE: 524742 | NSE: NA | ISIN: INE475E01018
Market Cap: [Rs.Cr.] 96 | Face Value: [Rs.] 10
Industry: Pharmaceuticals - Indian - Formulations
Discuss this stock
Products & Services
Jun-2012
Jun-2011
Jun-2010
Jun-2009
Jun-2008
Mar-2007
Jun-2006
Jun-2005
Mar-2004
Mar-2003
Product Name
Unit
% of Stock
% Cap. Util.
Inst. Prod. Cap
Prodn
Sales Qty
Sales (Cr.)
Sales (Rs.) / Unit
Tablets
No
32.0
0.0
0
0
0
34.81
-
Capsules-Traded
NA
17.3
0.0
0
0
0
18.84
-
Tablets-Traded
NA
15.8
0.0
0
0
0
17.22
-
Injectables-Traded
NA
9.5
0.0
0
0
0
10.30
-
Liquids
No
5.0
0.0
0
0
0
5.46
-
Other Operating Revenue
NA
5.0
0.0
0
0
0
5.41
-
Capsules
No
3.7
0.0
0
0
0
4.04
-
Liquids (Traded goods)
NA
3.7
0.0
0
0
0
4.03
-
Others-Traded
NA
3.7
0.0
0
0
0
4.01
-
Ointment-Traded
NA
3.0
0.0
0
0
0
3.28
-
Excise duty
NA
1.0
0.0
0
0
0
1.10
-
Others
NA
0.1
0.0
0
0
0
0.14
-
Ointment
No
0.1
0.0
0
0
0
0.06
-
Injections
No
0.0
0.0
0
0
0
0.02
-
Job Work Charges
NA
0.0
0.0
0
0
0
0.00
-
Sales
NA
0.0
0.0
0
0
0
0.00
-
Unspecified
NA
0.0
0.0
0
0
0
0.00
-
Pharmaceutical Formulations
No
0.0
0.0
0
0
0
0.00
-
Pharmaceutical Formult. Traded
No
0.0
0.0
0
0
0
0.00
-
Powder
No
0.0
0.0
0
0
0
0.00
-
India Infoline Research
Company
|
Sectors
No Related Research Found
Related News
Company
|
Sector
|
Latest
15-Feb-13
Caplin Point Laboratories net profit rises 75.49% in the December 2012 quarter
12-Nov-12
Caplin Point Laboratories net profit rises 344.72% in the September 2012 quarter
12-Nov-12
Caplin Point Laboratories recommends final dividend
03-Nov-12
Caplin Point Laboratories to consider dividend
10-Oct-12
Caplin Point Laboratories appoints director
17-Aug-12
Caplin Point Laboratories net profit rises 141.88% in the June 2012 quarter
More News
Peer Comparison
Company
Market Cap
(Rs. in Cr.)
P/E (TTM)
(x)
P/BV (TTM)
(x)
EV/EBIDTA
(x)
ROE
(%)
ROCE
(%)
D/E
(x)
Ajanta Pharma
2,251.76
22.27
6.32
5.40
27.3
24.2
0.72
Plethico Pharma.
694.01
60.27
1.27
33.34
-5.5
3.8
1.08
Sharon Bio-Med.
363.84
7.06
1.99
9.58
19.1
14.1
1.85
Bliss GVS Pharma
314.46
5.36
1.49
2.15
28.0
42.7
0.04
Venus Remedies
294.43
5.15
0.76
3.54
17.7
16.9
0.72
Kappac Pharma
266.11
0.00
11.10
0.00
0.0
0.0
0.06
Ahlcon Parent(I)
260.64
20.25
4.82
22.59
12.6
17.0
0.59
Syncom Formul.
254.33
73.11
3.04
13.86
4.3
6.7
0.09
Parenteral Drugs
251.20
0.00
0.99
58.93
-16.1
-0.7
0.86
Amrutanjan Healt
188.85
16.07
1.89
9.89
12.6
16.3
0.23
Arvind Remedies
153.13
3.77
1.13
6.60
15.1
16.1
2.12
Combat Drugs
101.52
0.00
17.55
0.00
0.3
0.3
0.07
Zenotech Lab.
100.71
0.00
1.95
0.00
0.0
0.0
0.08
Caplin Point Lab
96.02
6.18
3.17
1.38
29.3
33.1
0.30
Hester Bios
93.61
11.52
1.56
4.56
14.4
20.6
0.35
Prev
Next
Futures & Options Quote
Future
|
Option
Expiry Date
Stock not available in F&O
NA
Instrument:
NA
Expiry Date:
NA
Strike Price:
NA
Open Price:
NA
Average Price:
NA
No. of Contracts Traded:
NA
Open Interest:
NA
Underlying:
NA
Option Type:
NA
Market Lot:
NA
Previous Close:
NA
Day’s High | Low:
NA | NA
Turnover (Cr.):
NA
Open Int. Change:
NA | NA
View detailed F& O quotes >>
Key Information
Key Executives:
C C Paarthipan , Chairman
M Jayapal , Managing Director
P T Baby Thomas , Director
V Thirumalai , Director
Company Head Office / Quarters:
Narbavi No 3 Lakshmanan Street,
T Nagar,
Chennai,
Tamil Nadu-600017
Phone : 044-28156653/28156905
Fax :
E-mail :
tricap@md3.vsnl.net.in
Web :
http://www.caplinpoint.net
Registrars:
Knack Corporate Services Pvt L
New No 2 Karpagam
Avenue 12th Cross
Mandaveli
Chennai-600028
Fund Holding
Mutual Funds
|
Fll
Scheme Name
No. of Shares
No data found
Calendar
May-2013
M
T
W
T
F
S
S
20
21
22
23
24
25
26
IPO
No IPO today
View full month IPO calendar
Economic Events
Foreign Buying Japan Stocks (Yen)
Balance (YTD) (New Zealand dollars)
View full month Economic Events calendar
Results
Tata Steel | St Bk of India | B H E L | Hind.Copper
View full month Results calendar